0001250853-21-000086.txt : 20210830
0001250853-21-000086.hdr.sgml : 20210830
20210830152017
ACCESSION NUMBER: 0001250853-21-000086
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210827
FILED AS OF DATE: 20210830
DATE AS OF CHANGE: 20210830
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MONTGOMERY HERBERT D
CENTRAL INDEX KEY: 0001022265
STANDARD INDUSTRIAL CLASSIFICATION: HEAVY CONSTRUCTION OTHER THAN BUILDING CONST - CONTRACTORS [1600]
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36225
FILM NUMBER: 211223272
MAIL ADDRESS:
STREET 1: C/O ATKINSON
STREET 2: 1001 BAYHILL DRIVE 2ND FL
CITY: SAN BRUNO
STATE: CA
ZIP: 94066
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kindred Biosciences, Inc.
CENTRAL INDEX KEY: 0001561743
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461160142
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1555 BAYSHORE HIGHWAY, SUITE 200
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: 650-701-7901
MAIL ADDRESS:
STREET 1: 1555 BAYSHORE HIGHWAY, SUITE 200
CITY: BURLINGAME
STATE: CA
ZIP: 94010
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2021-08-27
1
0001561743
Kindred Biosciences, Inc.
KIN
0001022265
MONTGOMERY HERBERT D
C/O KINDRED BIOSCIENCES, INC.
1555 BAYSHORE HIGHWAY, SUITE 200
BURLINGAME
CA
94010
1
0
0
0
Stock Option (right to buy)
3.52
2021-08-27
4
D
0
27500
5.73
D
2026-04-15
Common Stock
27500
0
D
Stock Option (right to buy)
4.14
2021-08-27
4
D
0
3350
5.11
D
2026-05-26
Common Stock
3350
0
D
Stock Option (right to buy)
6.4
2021-08-27
4
D
0
49900
2.85
D
2027-01-23
Common Stock
49900
0
D
Stock Option (right to buy)
8.75
2021-08-27
4
D
0
75000
0.5
D
2028-01-22
Common Stock
75000
0
D
Stock Option (right to buy)
9.91
2021-08-27
4
D
0
51500
0
D
2029-01-31
Common Stock
51500
0
D
Stock Option (right to buy)
9.84
2021-08-27
4
D
0
51500
0
D
2030-01-16
Common Stock
51500
0
D
Stock Option (right to buy)
4.44
2021-08-27
4
D
0
51500
4.81
D
2031-01-19
Common Stock
51500
0
D
This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the agreement and plan of merger, dated as of June 15, 2021, by and among the Elanco Animal Health Incorporated, Knight Merger Sub, Inc., and Kindred Biosciences, Inc. (the "Merger Agreement") in exchange for a cash payment of $157,575.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share.
This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $17,118.50, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share.
This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $142,215.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share.
This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $37,500.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share.
This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for no consideration.
This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for no consideration.
This option provided for vesting in four equal quarterly installments from the option grant date. Pursuant to the Merger Agreement, the unvested portion of this option was subject to acceleration of vesting. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $247,715.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share.
/s/ Herbert Montgomery
2021-08-27